Dalvance Injection, Powder, For Solution
Product Images NDC 57970-100
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dalvance (NDC 57970-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2. Mean (± Standard Deviation) Dalbavancin Plasma Concentrations Versus Time In Healthy Subjects (n=10) Following Iv Administration Over 30 Minutes Of 1000 mg Dalbavancin (day 1) And 500 mg Dalbavancin (day 8). (Dalvance 02)
Principal Display Panelndc 57970-100-01rx Onlydalvance® (dalbavancin) For Injection500 mg Per Vialfor Intravenous Infusion Onlysterile Single-dose Vialdiscard Unused Portionabbvieone Vial (Dalvance 03)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.